dsco Discovery Laboratories Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : dsco Discovery Laboratories

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (234)	4/20/2009 3:21:04 PM
From: rkrw	1 Recommendation Read Replies (1) of 318

OT. Amln. My thoughts for whatever they're worth and just shooting from hip. A few years ago it was thought a 1/week would blow open the market potential, but now i'm not so sure that holds true. Uncomfortable needle size, docs may be uncomfortable on pancreatitis even though it's probably way overblown, byetta itself has peaked and flattened out at a lower than expected level and LAR approval itself at least first pass is probably a higher risk than would have been previously thought after the liraglutide (Novo Nordisk) panel.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next